Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS-Reference-Cited by-同舟云学术

Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS

Published:2016-05-16 Issue:5 Volume:11 Page:e0155629
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Deere Jesse D.,Chang W. L. William,Castillo Luis D.,Schmidt Kim A.,Kieu Hung T.,Renzette Nicholas,Kowalik Timothy,Barthold Stephen W.,Shacklett Barbara L.,Barry Peter A.,Sparger Ellen E.

Funder

National Institutes of Health

California National Primate Research Center

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel;HF Gunthard;JAMA: the journal of the American Medical Association,2014

2. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy;S Palmer;Proceedings of the National Academy of Sciences of the United States of America,2008

3. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication;TW Chun;AIDS,2010

4. The end of AIDS: HIV infection as a chronic disease;SG Deeks;Lancet,2013

5. HIV infection, inflammation, immunosenescence, and aging;SG Deeks;Annual review of medicine,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection;PLOS Pathogens;2023-10-05

2. Coevolution based immunoinformatics approach considering variability of epitopes to combat different strains: A case study using spike protein of SARS-CoV-2;Computers in Biology and Medicine;2023-09

3. Protective effect of pre-existing natural immunity in a nonhuman primate reinfection model of congenital cytomegalovirus infection;2023-04-10

4. Host factors: Implications in immunopathogenesis of COVID-19;Pathology - Research and Practice;2021-12

5. RhCMV serostatus and vaccine adjuvant impact immunogenicity of RhCMV/SIV vaccines;Scientific Reports;2020-08-20